Organogenesis Holdings Inc
NASDAQ:ORGO

Watchlist Manager
Organogenesis Holdings Inc Logo
Organogenesis Holdings Inc
NASDAQ:ORGO
Watchlist
Price: 3.765 USD -15.01%
Market Cap: 499.1m USD
Have any thoughts about
Organogenesis Holdings Inc?
Write Note

Relative Value

The Relative Value of one ORGO stock under the Base Case scenario is 6.128 USD. Compared to the current market price of 3.765 USD, Organogenesis Holdings Inc is Undervalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ORGO Relative Value
Base Case
6.128 USD
Undervaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
65
vs Industry
88
Median 3Y
0.9
Median 5Y
1.3
Industry
8.1
Forward
1.1
vs History
vs Industry
3
Median 3Y
19.7
Median 5Y
12.1
Industry
23
Forward
-21.7
vs History
23
vs Industry
10
Median 3Y
14.9
Median 5Y
14.3
Industry
23.4
vs History
vs Industry
2
Median 3Y
-24.5
Median 5Y
-24.5
Industry
27.3
vs History
66
vs Industry
54
Median 3Y
1.6
Median 5Y
3.4
Industry
2.6
vs History
65
vs Industry
79
Median 3Y
0.9
Median 5Y
1.5
Industry
8.1
Forward
1
vs History
63
vs Industry
75
Median 3Y
1.1
Median 5Y
2
Industry
9.6
vs History
33
vs Industry
9
Median 3Y
11.9
Median 5Y
11.9
Industry
4.3
Forward
27.4
vs History
17
vs Industry
4
Median 3Y
16.8
Median 5Y
16.8
Industry
3.8
Forward
-22
vs History
25
vs Industry
10
Median 3Y
13.7
Median 5Y
13.1
Industry
6
vs History
22
vs Industry
3
Median 3Y
31
Median 5Y
21.1
Industry
3.8
vs History
68
vs Industry
58
Median 3Y
1.2
Median 5Y
2.5
Industry
4.8

Multiples Across Competitors

ORGO Competitors Multiples
Organogenesis Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Organogenesis Holdings Inc
NASDAQ:ORGO
499.1m USD 1.1 -30.2 16.6 39.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
300.2B USD 5.4 59 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.4 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD 11.9 -263.9 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 4.1 910.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.7 20.8 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 6.3 18.8 17.3 19.2
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
US
Organogenesis Holdings Inc
NASDAQ:ORGO
Average P/E: 211.8
Negative Multiple: -30.2
37%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.7
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Organogenesis Holdings Inc
NASDAQ:ORGO
Average EV/EBITDA: 17.7
16.6
64%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.8
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
US
Organogenesis Holdings Inc
NASDAQ:ORGO
Average EV/EBIT: 25.5
39.1
14%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
25.9
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top